Welcome to medications.com

Risperdal Consta News

Study finds IONSYS (TM), a New Needle-Free System for Management ... - ITNews

... behavioural psychological symptoms of dementia, disruptive behaviour disorders, autism) and RISPERDAL(R), CONSTA(TM) (schizophrenia). ...

http://www.itnews.it/news/2008/03... | Posted: Tue Mar 04 01:02:18 -0500 2008

Study finds IONSYS (TM), a New Needle-Free System for Management ... - ITNews

... behavioural psychological symptoms of dementia, disruptive behaviour disorders, autism) and RISPERDAL(R), CONSTA(TM) (schizophrenia). ...

Posted: Tue Mar 04 01:02:18 -0500 2008

FDA rejects injectable Zyprexa - Indianapolis Star

That version of the drug, Risperdal Consta, is manufactured by Alkermes and already has achieved blockbuster status by exceeding $1.1 billion in annual ...

http://www.indystar.com/apps/pbcs... | Posted: Fri Feb 29 02:50:26 -0500 2008

FDA Floors Eli Lilly - Motley Fool

Johnson & Johnson's (NYSE: JNJ) and Alkermes' (Nasdaq: ALKS) Risperdal Consta, which had sales of $1.1 billion last year, is the only long-acting atypical ...

Posted: Fri Feb 29 15:31:42 -0500 2008

UPDATE: Lilly shares slip following Zyprexa news - Indianapolis Business Journal

The only approved drug similar to long-acting Zyprexa is Risperdal Consta, which is sold by a subsidiary of New Jersey-based Johnson & Johnson. ...

http://cms.ibj.com/ASPXPages/6ifr... | Posted: Thu Feb 28 11:39:59 -0500 2008

Alkermes Should Profit From Lilly's Delayed Drug - Seeking Alpha

all 8 news articles

Posted: Fri Feb 29 08:30:49 -0500 2008

UPDATE: Lilly shares slip following Zyprexa news - Indianapolis Business Journal

The only approved drug similar to long-acting Zyprexa is Risperdal Consta, which is sold by a subsidiary of New Jersey-based Johnson & Johnson. ...

Posted: Thu Feb 28 11:39:59 -0500 2008

Alkermes' Corporate Presentation to be Webcast at the Merrill ... - Business Wire (press release)

Alkermes manufactures RISPERDAL ® CONSTA ® , marketed by Janssen-Cilag (Janssen, LP), a wholly owned division of Johnson & Johnson, and developed and ...

http://www.businesswire.com/porta... | Posted: Tue Jan 29 16:36:10 -0500 2008

FDA staff cites sedation concern with Lilly drug - Scientific American

Zyprexa Adhera would compete with Johnson & Johnson's long-acting schizophrenia injection called Risperdal Consta. Lilly shares rose 43 cents to $52.09 in ...

http://www.sciam.com/article.cfm?... | Posted: Mon Feb 04 13:56:13 -0500 2008

Alkermes Announces $60 Million Accelerated Share Repurchase Program - WELT ONLINE

Alkermes manufactures RISPERDAL® CONSTA®, marketed by divisions of Johnson & Johnson, and developed and manufactures VIVITROL®, marketed in the US primarily ...

http://newsticker.welt.de/index.p... | Posted: Thu Feb 07 16:18:59 -0500 2008




ADVERTISEMENT
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com